Skip to content

UROPLASTY INC: 10-Q filed 2014-10-31

What UROPLASTY INC reported in its quarterly report filed 2014-10-31 (fiscal Q2 2015): 35 published measures, 94 facts as tagged in accession 0001140361-14-039710.

This filing

Form
10-Q (quarterly report)
Filed
2014-10-31
Fiscal period
fiscal Q2 2015
Accession
0001140361-14-039710 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All UROPLASTY INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-09-3014,440,817USD
At 2014-03-3117,301,046USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-09-303,892,074USD
At 2014-03-314,087,346USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-09-3010,548,743USD
At 2014-03-3113,213,700USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-09-309,540,168USD
At 2014-03-318,681,609USD
At 2013-09-307,091,758USD
At 2013-03-313,533,864USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-1,080,246USD92
2014-04-01 to 2014-09-30-3,270,579USD183
2013-07-01 to 2013-09-30-1,927,480USD92
2013-04-01 to 2013-09-30-3,536,772USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-04-01 to 2014-09-30-2,475,749USD183
2013-04-01 to 2013-09-30-2,242,895USD183

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-04-01 to 2014-09-30128,041USD183
2013-04-01 to 2013-09-30208,768USD183

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-07-01 to 2014-09-306,455,000USD92
2014-04-01 to 2014-09-3012,839,000USD183
2013-07-01 to 2013-09-305,977,000USD92
2013-04-01 to 2013-09-3011,818,000USD183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-04-01 to 2014-09-3067,850USD183
2013-04-01 to 2013-09-3069,360USD183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-04-01 to 2014-09-303,323,511USD183
2013-04-01 to 2013-09-305,696,705USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-09-30-47,444,650USD
At 2014-03-31-44,174,071USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-07-01 to 2014-09-3015,032USD92
2014-04-01 to 2014-09-3034,847USD183
2013-07-01 to 2013-09-3016,367USD92
2013-04-01 to 2013-09-3030,542USD183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-09-30952,910USD
At 2014-03-31997,609USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-04-01 to 2014-09-30660,891USD183
2013-04-01 to 2013-09-30920,729USD183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-1,064,857USD92
2014-04-01 to 2014-09-30-3,239,298USD183
2013-07-01 to 2013-09-30-1,915,250USD92
2013-04-01 to 2013-09-30-3,516,936USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-09-3013,248,073USD
At 2014-03-3116,032,486USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-09-303,277,103USD
At 2014-03-313,409,057USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-09-30670,832USD
At 2014-03-31904,879USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-09-302,663,403USD
At 2014-03-312,875,275USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-07-01 to 2014-09-306,766,262USD92
2014-04-01 to 2014-09-3014,534,021USD183
2013-07-01 to 2013-09-307,150,283USD92
2013-04-01 to 2013-09-3013,844,763USD183

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-09-30526,367USD
At 2014-03-31517,217USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-305,701,405USD92
2014-04-01 to 2014-09-3011,294,723USD183
2013-07-01 to 2013-09-305,235,033USD92
2013-04-01 to 2013-09-3010,327,827USD183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-07-01 to 2014-09-30651,035USD92
2014-04-01 to 2014-09-301,560,479USD183
2013-07-01 to 2013-09-30428,763USD92
2013-04-01 to 2013-09-30908,423USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-09-3022,131,518shares
At 2014-03-3121,653,835shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-09-30-596,661USD
At 2014-03-31-484,395USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-09-30103,428USD
At 2014-03-31119,980USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-1,190,584USD92
2014-04-01 to 2014-09-30-3,382,845USD183
2013-07-01 to 2013-09-30-1,867,935USD92
2013-04-01 to 2013-09-30-3,460,091USD183

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-301,288,297USD92
2014-04-01 to 2014-09-302,865,665USD183
2013-07-01 to 2013-09-302,390,610USD92
2013-04-01 to 2013-09-303,971,373USD183

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2014-04-01 to 2014-09-30139,252USD183
2013-04-01 to 2013-09-30179,123USD183

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-07-01 to 2014-09-308,226USD92
2014-04-01 to 2014-09-3016,552USD183
2013-07-01 to 2013-09-307,826USD92
2013-04-01 to 2013-09-3014,474USD183

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-357USD92
2014-04-01 to 2014-09-303,566USD183
2013-07-01 to 2013-09-304,137USD92
2013-04-01 to 2013-09-3010,706USD183

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2014-04-01 to 2014-09-301,973USD183
2013-04-01 to 2013-09-304,979USD183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-04-01 to 2014-09-30-155,498USD183
2013-04-01 to 2013-09-30-197,216USD183

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-04-01 to 2014-09-3010,822USD183
2013-04-01 to 2013-09-30-97,787USD183

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-04-01 to 2014-09-30-230,103USD183
2013-04-01 to 2013-09-3051,232USD183

Inspect the source

Entity
UROPLASTY INC / CIK 0000890846
Captured
SEC response SHA-256
19849e6278f98a98bf135df02adb6fd292e8724ef3ceac26af63b4fe931981a9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000890846.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))